<?xml version="1.0" encoding="UTF-8"?>
<ref id="B159">
 <label>159.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Arabi</surname>
    <given-names>YM</given-names>
   </name>
   <name>
    <surname>Alothman</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Balkhy</surname>
    <given-names>HH</given-names>
   </name>
   <name>
    <surname>Al-Dawood</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>AlJohani</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Al Harbi</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-β1b (MIRACLE trial): study protocol for a randomized controlled trial</article-title>. 
  <source>Trials.</source> (
  <year>2018</year>) 
  <volume>19</volume>:
  <fpage>1</fpage>–
  <lpage>13</lpage>. 
  <pub-id pub-id-type="doi">10.1186/s13063-017-2427-0</pub-id>
  <?supplied-pmid 29382391?>
  <pub-id pub-id-type="pmid">29298706</pub-id>
 </mixed-citation>
</ref>
